AbbVie Inc. Annual Amortization of Intangible Assets in USD from 2011 to 2023

Taxonomy & unit
us-gaap: USD
Description
The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.
Summary
AbbVie Inc. quarterly/annual Amortization of Intangible Assets history and growth rate from 2011 to 2023.
  • AbbVie Inc. Amortization of Intangible Assets for the quarter ending June 30, 2024 was $1.9B, a 9.52% decline year-over-year.
  • AbbVie Inc. Amortization of Intangible Assets for the twelve months ending June 30, 2024 was $7.69B, a 4.86% decline year-over-year.
  • AbbVie Inc. annual Amortization of Intangible Assets for 2023 was $7.95B, a 3.34% increase from 2022.
  • AbbVie Inc. annual Amortization of Intangible Assets for 2022 was $7.69B, a 0.38% decline from 2021.
  • AbbVie Inc. annual Amortization of Intangible Assets for 2021 was $7.72B, a 33% increase from 2020.
Amortization of Intangible Assets, Trailing 12 Months (USD)
Amortization of Intangible Assets, Annual (USD)
Amortization of Intangible Assets, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $7.95B +$257M +3.34% Jan 1, 2023 Dec 31, 2023 10-K 2024-02-20
2022 $7.69B -$29M -0.38% Jan 1, 2022 Dec 31, 2022 10-K 2024-02-20
2021 $7.72B +$1.91B +33% Jan 1, 2021 Dec 31, 2021 10-K 2024-02-20
2020 $5.81B +$4.25B +274% Jan 1, 2020 Dec 31, 2020 10-K 2023-02-17
2019 $1.55B +$259M +20% Jan 1, 2019 Dec 31, 2019 10-K 2022-02-18
2018 $1.29B +$218M +20.3% Jan 1, 2018 Dec 31, 2018 10-K 2021-02-19
2017 $1.08B +$312M +40.8% Jan 1, 2017 Dec 31, 2017 10-K 2020-02-21
2016 $764M +$345M +82.3% Jan 1, 2016 Dec 31, 2016 10-K 2019-02-27
2015 $419M +$16M +3.97% Jan 1, 2015 Dec 31, 2015 10-K 2018-02-16
2014 $403M -$106M -20.8% Jan 1, 2014 Dec 31, 2014 10-K 2017-02-17
2013 $509M -$116M -18.6% Jan 1, 2013 Dec 31, 2013 10-K 2016-02-19
2012 $625M -$139M -18.2% Jan 1, 2012 Dec 31, 2012 10-K 2015-02-20
2011 $764M Jan 1, 2011 Dec 31, 2011 10-K 2014-02-21
* An asterisk sign (*) next to the value indicates that the value is likely invalid.